You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. METTL3-mediated SNHG1 m6A modification promotes proliferation and migration through transcriptional regulation of WDR74 in osteosarcoma
- 2. New AI test can predict which men will benefit from prostate cancer drug
- 3. Landscape of targets within nucleoside metabolism for the modification of immune responses
- 4. TFRC promotes the proliferation, migration, and invasion of osteosarcoma cells by increasing the intracellular iron content and RRM2 expression
- 5. Bi-modal ultrasound radiomics and habitat analysis enhanced the pre-operative prediction of axillary lymph node burden in patients with early-stage breast cancer
- 6. Advances on cancer vaccine trials registered in China and the USA in 2014-2024
- 7. Unveiling the impact of lipid metabolism on triple-negative breast cancer growth and treatment options
- 8. Enhanced coagulation index: a potent prognostic indicator for clinical outcomes in non-metastatic breast cancer following surgery and adjuvant therapy
- 9. Intensity Therapeutics, Inc.'s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
- 10. Accelerating cancer genomics research in Sub-Saharan Africa
Last updated at 17:04 GMT
Hot News Makers
Health/Pharma Companies
- 158408.91
- 62006.35
- 38516.24
- 28566.88
- 11113.91
- 10543.18
- 9633.74
- 9062.07
- 8519.15
- 7395.96
Drugs, Treatments, Trials
- 16386.10
- 14044.29
- 13255.17
- 13226.68
- 12024.25
- 9875.60
- 8941.91
- 7658.71
- 5704.40
- 5633.16
Last updated at 16:10 GMT
